WO2025238556 - AN INHALER
National phase entry is expected:
Publication Number
WO/2025/238556
Publication Date
20.11.2025
International Application No.
PCT/IB2025/055019
International Filing Date
13.05.2025
Title **
[English]
AN INHALER
[French]
INHALATEUR
Applicants **
ASTRAZENECA AB
SE-151 85
Södertälje, SE
Inventors
FOSTER, Brian
c/o AstraZeneca Pharmaceuticals LP
1800 Concord Pike
P.O. Box 15437
Wilmington, Delaware 19850-5437, US
DEATON, Dan
c/o AstraZeneca Pharmaceuticals LP
1800 Concord Pike
P.O. Box 15437
Wilmington, Delaware 19850-5437, US
COONEY, Daniel
c/o AstraZeneca Pharmaceuticals LP
1800 Concord Pike
P.O. Box 15437
Wilmington, Delaware 19850-5437, US
HANNON, James
c/o AstraZeneca Pharmaceuticals LP
1800 Concord Pike
P.O. Box 15437
Wilmington, Delaware 19850-5437, US
RICHARDSON, Eric
c/o Knightpoint Group LLC
3010 Leith Meadow Court
Cary, North Carolina 27511, US
HAYTON, Paul
c/o Crux Product Design Limited
Flatiron Building, 332-336 Paintworks
Bristol BS4 3AR, GB
MCLENNAN, Cal
c/o Crux Product Design Limited
Flatiron Building, 332-336 Paintworks
Bristol BS4 3AR, GB
WILSON, Pete
c/o Team Consulting Limited
Abbey Barnes, Duxford Road
Ickelton, Cambridge CB10 1SX, GB
ETHERIDGE, Tom
c/o Team Consulting Limited
Abbey Barnes, Duxford Road
Ickelton, Cambridge CB10 1SX, GB
ROBINSON, David George
c/o Team Consulting Limited
Abbey Barnes, Duxford Road
Ickelton, Cambridge CB10 1SX, GB
Priority Data
18/666,606
16.05.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1348 | |
| EPO | Filing, Examination | 6011 | |
| Japan | Filing | 588 | |
| South Korea | Filing | 574 | |
| USA | Filing, Examination | 2710 |
Total: 11231 USD
Abstract[English]
An inhaler (100, 200, 300, 400) includes a main body (101) and a drawer (102) to open out of and close into the main body between an open position and a closed position. The drawer includes a spin chamber (103) having a primary recess (104) to receive air to mix with contents of a capsule (213) and a secondary recess (105) to hold the capsule. When the drawer is in the open position, the secondary recess is exposed to receive a new capsule therein or to withdraw a used capsule therefrom. When the drawer is in the closed position, the capsule is enclosed within the inhaler. The inhaler includes a perforating means (204) to perforate the capsule. The perforating means moves away from a resting position toward a perforating position as the drawer moves into the main body. When set at the perforating position, the perforating means is positioned within the secondary recess to perforate the capsule.[French]
L'invention concerne un inhalateur (100, 200, 300, 400) comprenant un corps principal (101) et un tiroir (102) destiné à s'ouvrir et à se fermer dans le corps principal entre une position ouverte et une position fermée. Le tiroir comprend une chambre de rotation (103) comportant une cavité principale (104) destinée à recevoir de l'air qui se mélange au contenu d'une capsule (213), et une cavité secondaire (105) destinée à contenir la capsule. Lorsque le tiroir se trouve en position ouverte, la cavité secondaire est exposée afin d'y recevoir une nouvelle capsule ou d'en retirer une capsule usagée. Lorsque le tiroir se trouve en position fermée, la capsule est enfermée dans l'inhalateur. L'inhalateur comprend un moyen de perforation (204) pour perforer la capsule. Le moyen de perforation s'éloigne d'une position de repos vers une position de perforation lorsque le tiroir se déplace dans le corps principal. Lorsqu'il est réglé à la position de perforation, le moyen de perforation est positionné dans la cavité secondaire afin de perforer la capsule.